Sun Young Kim Selected Research

Sun Young Kim Research Topics

Disease

107	Neoplasms (Cancer) 10/2022 - 04/2005
61	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 02/2009
48	Rectal Neoplasms (Rectal Cancer) 01/2021 - 03/2010
22	Neoplasm Metastasis (Metastasis) 07/2022 - 02/2002
16	Colonic Neoplasms (Colon Cancer) 11/2022 - 02/2009
11	Stomach Neoplasms (Stomach Cancer) 01/2019 - 10/2005
10	Inflammation (Inflammations) 01/2020 - 08/2010
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2011
9	Adenocarcinoma 01/2021 - 10/2005
6	Infections 03/2022 - 10/2011
5	Disease Progression 01/2022 - 11/2012
5	Breast Neoplasms (Breast Cancer) 11/2018 - 01/2008
5	Carcinoma (Carcinomatosis) 07/2017 - 06/2007
4	Nausea 10/2022 - 02/2010
4	Microsatellite Instability 01/2022 - 05/2017
4	Type 2 Diabetes Mellitus (MODY) 04/2021 - 05/2007
4	Hypoxia (Hypoxemia) 07/2015 - 07/2009
3	Vomiting 10/2022 - 02/2010
3	Fatigue 10/2022 - 07/2010
3	Tuberculosis (Tuberculoses) 03/2022 - 02/2010
3	Thrombocytopenia (Thrombopenia) 01/2021 - 10/2014
3	Sepsis (Septicemia) 12/2020 - 01/2018
3	Hematologic Neoplasms (Hematological Malignancy) 10/2018 - 04/2006
3	Guillain-Barre Syndrome 07/2018 - 03/2013
3	Margins of Excision 04/2018 - 07/2010
3	Pathologic Complete Response 03/2017 - 02/2009
3	Carcinogenesis 10/2016 - 05/2014
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016 - 01/2007
3	Neutropenia 10/2014 - 05/2013
3	Necrosis 04/2014 - 09/2009
2	Diarrhea 10/2022 - 04/2014
2	Diabetes Mellitus 04/2021 - 02/2013
2	Colitis 10/2020 - 09/2017
2	Non-alcoholic Fatty Liver Disease 11/2019 - 11/2015
2	Glaucoma 11/2019 - 07/2012
2	Melanoma (Melanoma, Malignant) 06/2019 - 01/2018
2	Thrombosis (Thrombus) 08/2018 - 10/2011
2	Peripheral Nervous System Diseases (PNS Diseases) 07/2018 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2018 - 04/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 10/2016
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 06/2016
2	Cataract (Cataracts) 07/2017 - 02/2013

Drug/Important Bio-Agent (IBA)

21	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 06/2009
15	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2007
15	Capecitabine (Xeloda)FDA Link 01/2021 - 02/2008
12	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2013
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2007
11	Pharmaceutical PreparationsIBA 06/2022 - 08/2010
11	Cetuximab (Erbitux)FDA Link 01/2022 - 06/2009
9	Biological ProductsIBA 01/2022 - 08/2011
8	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 12/2012
8	Carcinoembryonic AntigenIBA 02/2016 - 07/2010
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 04/2008
7	Bevacizumab (Avastin)FDA Link 01/2021 - 07/2009
7	Leucovorin (Folinic Acid)FDA Link 01/2021 - 04/2013
7	ErbB Receptors (EGF Receptor)IBA 01/2018 - 06/2009
6	Messenger RNA (mRNA)IBA 12/2019 - 09/2007
6	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 01/2007
5	SteroidsIBA 03/2022 - 02/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2012
5	Tyrosine Kinase InhibitorsIBA 12/2019 - 03/2012
4	Immunoglobulin G (IgG)IBA 01/2021 - 09/2007
4	Therapeutic UsesIBA 12/2020 - 02/2015
4	AntigensIBA 01/2018 - 02/2010
3	Calcibiotic Root Canal SealerIBA 11/2022 - 11/2013
3	Lactic Acid (Lactate)FDA LinkGeneric 10/2022 - 07/2016
3	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2017
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 01/2008
3	Gefitinib (Iressa)FDA Link 11/2018 - 02/2014
3	Phosphotransferases (Kinase)IBA 01/2018 - 08/2010
3	Epithelial Cell Adhesion MoleculeIBA 07/2017 - 10/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 11/2010
3	Capsules (Microcapsules)IBA 10/2013 - 09/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 09/2009
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 06/2021
2	Estrogens (Estrogen)FDA Link 01/2022 - 05/2013
2	CKD-497IBA 01/2021 - 07/2020
2	AcidsIBA 12/2020 - 05/2014
2	Dextran SulfateIBA 10/2020 - 09/2017
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 05/2014
2	regorafenibIBA 12/2019 - 07/2019
2	AntibodiesIBA 07/2018 - 04/2014
2	MucinsIBA 05/2018 - 01/2012
2	Panitumumab (Vectibix)FDA Link 01/2018 - 11/2016
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 10/2016
2	AZD4547IBA 08/2017 - 05/2017
2	Adenosine Triphosphate (ATP)IBA 03/2017 - 06/2013

Therapy/Procedure

42	Drug Therapy (Chemotherapy) 05/2022 - 02/2009
41	Therapeutics 11/2022 - 01/2003
40	Chemoradiotherapy 01/2021 - 03/2010
10	Radiotherapy 07/2022 - 06/2010
8	Adjuvant Chemotherapy 01/2022 - 07/2010
6	Neoadjuvant Therapy 01/2021 - 07/2010
4	Palliative Care (Palliative Therapy) 01/2022 - 07/2010
3	Salvage Therapy 11/2017 - 11/2010
3	Metastasectomy 06/2013 - 02/2009
2	Radiofrequency Ablation 07/2022 - 07/2013
2	Resuscitation 04/2020 - 01/2018
2	Oral Administration 09/2017 - 01/2017
2	Intraocular Lenses (Intraocular Lens) 07/2017 - 02/2013